You are here
- Home
- Last 30 days trials
A Randomized Phase II Trial of Temozolomide (TMZ) with/without Recentin (AZD2171) in Patients with unresectable Stage IV Malignant Melanoma.
- Disease
- colorectal cancer
- Drug Name
- RECENTIN
- Generic Name
- AZD2171
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Jan 18, 1971
- Study Id
- IRUS21710038
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
